1.
J Drugs Dermatol
; 21(10): 1138-1139, 2022 Oct 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36219047
RESUMEN
Disease control for moderate to severe atopic dermatitis (AD) has been primarily achieved with phototherapy and non-specific immunomodulators, cyclosporine, and methotrexate. These treatments have, however, been associated with many unfavorable side effects.